NDC 50090-6253-01 - POTASSIUM CHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6253
- Requested NDC
- 50090-6253-01
- Package NDCs from labels
- 50090-6253-1, 50090-6253-2, 50090-6253-0, 50090-6253-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-07-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2025-07-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6253-0 | POTASSIUM CHLORIDE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 5 | |
| 50090-6253-1 | POTASSIUM CHLORIDE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 5 | |
| 50090-6253-2 | POTASSIUM CHLORIDE | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6253 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 3 package rows | 20230913_14db14ba-fd0d-4b2a-9f1c-a62b3b82306f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6253-0 | EA - Each | 50090-6253 | c85cfeb8-7122-4a81-a822-0b28a55254f0 | 1 | 2023-01-09 |
| 50090-6253-1 | EA - Each | 50090-6253 | 5321c775-de27-45ea-8508-53ded35ec328 | 1 | 2023-01-09 |
| 50090-6253-2 | EA - Each | 50090-6253 | 20f380d6-6830-4ec6-805a-e61a393fd8a3 | 1 | 2023-01-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Granules India Ltd | 113c031c-6de3-4497-a57d-9740b1ce08ac | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | IPG Pharmaceuticals, Inc. | 5dad0879-0f97-4c7d-98fa-baaed51cd2d8 | 2026-10-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | QUAGEN PHARMACEUTICALS LLC | 8fac192f-48ab-4def-9c3a-f1cd50b3e2b7 | 2026-09-29 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | American Health Packaging | 7c8dd5b0-db93-430f-8bf8-0318504f744c | 2026-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Saptalis Pharmaceuticals, LLC | 483f338e-a164-4c1f-a34e-fef3312cb7ec | 2026-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | c2028705-9e5b-424b-983a-1c7a71dedd74 | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9b26cc41-3725-4ef1-afdf-5992816d3b0d | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | REMEDYREPACK INC. | d1e55181-6f85-42c9-922c-808494b6399a | 2026-09-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2026-09-09 | Warnings, Adverse reactions | 1801294 660YQ98I10 |
| BMNP Kali Mur | KALIUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a546950-3f03-7abf-e063-6294a90a1968 | 2026-08-31 | Warnings | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | 2c407aaf-5d95-49ff-a5db-f1d7b5190334 | 2026-08-27 | Warnings, Adverse reactions | 1801298 660YQ98I10 |
| Electrolyte Plus | KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM | Deseret Biologicals, Inc. | e3564733-8b88-4753-9077-9d74004d8ec9 | 2026-08-25 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Cardinal Health 107, LLC | ea55ded1-e076-43de-ad3c-c75e7d0a4ebc | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Cardinal Health 107, LLC | fea3ae21-3395-437e-b773-b180e1c98801 | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Coupler LLC | 598f61d7-a665-5d02-e063-6394a90a8905 | 2026-08-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Preferred Pharmaceuticals Inc. | 3f19ed0e-6c73-482c-94d6-d3205318fd6f | 2026-08-17 | Warnings, Adverse reactions | 660YQ98I10 |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 660YQ98I10 |
| BM BM165 DROPS | ANGELICA ATRO, BALSAM PER, BARIUM MUR, GRINDELIA, KALI BICH, KALI IOD, KALI MUR, SILPHIUM LAC | BM Private Limited | 590301da-8f93-3b1e-e063-6394a90a1e72 | 2026-08-14 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Amneal Pharmaceuticals LLC | f9965f73-e189-423f-bd10-c4a0ed12b485 | 2026-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.